Using the hybrid expression of an array of specific genes, we have developed and algorithm which can predictively indicate the distant occurrence of cancer in healthy individuals or relapse (in case of trated individuals)
The algorithm can also be extended to speculate the various stage of cancer (I, II, III, IV) based on the genetic mutation
The technology can further provide primary and secondary locations of the legions and also potential next organ targets. Further provide mutation data at an organ level without needing to do a invasive biopsy.
The test requires an individual's peripheral blood sample
We have filed a US patent for our diagnostic technology
| Pet - Scan | CT - Scan | Liquid Biopsy | Tzar Labs | |
|---|---|---|---|---|
| Technology/Technique | Imaging | Imaging | Traditional Blood (detect CTC) & Tissue Biopsy study | Advanced - Blood Based study |
| Location detection | Precise location for Lesions greater than a certain size | Precise location for Lesions greater than a certain size | No location; indicates ONLY Presence of cancer in body | Location at organ level for all tumour sizes |
| Activity Level detection |  Yes for ONLY visible lesions; not macro |
 |
|
 Yes @ Macro Level; not at lesion level |
| Size | For large lesions |
For large lesions |
|
Yes @ Macro Level |
| Detection @ Stage of cancer | Stages 1b, 2, 3, 4 only for solid cancers | Stages 1b, 2, 3, 4 only for solid cancers | Stages 1, 2, 3, 4 for few cancers only; subject to false negatives | Stages 1, 2, 3, 4 & earlier; Applies for all cancer types |
| Frequency Limit | Once in 6-8 months | Once in 6-8 months | Blood test - Unlimited; Tissue biopsies - Limited | Unlimited |
| Drawbacks of PET, CT, & Liq Biopsy over Tzar Labs | ||||
| Hazardous | Radiation Equals ~ 70,000 xrays | Radiation Equals ~ 4000 xrays | Blood test - Not Hazardous; Biopsies - Highly Invasive | Non-Hazardous |
| Non-Carcinogenic | |
|
|
|
| Cancer types | Only applies to solid tumors NOT blood | Only applies to solid tumors NOT blood | Applies to Solid & Blood; but not relevant in many cancer types | All Cancers - Applies to Solid & Blood |
| Detection strengths | Stage 1A cannot be detected | Stage 1A cannot be detected | Not detected until shedding begins in Stage 2; History of False Negatives | Detected @ all stages including Pre - cancer (Before Stage-1); highly accurate |
| Scope | Diagnostic | Diagnostic | Diagnostic | Prognostic + Diagnostic |
| Post Manifestation of Tumour | Post Manifestation of Tumour | Post Manifestation of Tumour | Post + Pre Manifestation of tumour | |
